Clinical Trials Logo

NMO Spectrum Disorder clinical trials

View clinical trials related to NMO Spectrum Disorder.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03829566 Withdrawn - Clinical trials for Neuromyelitis Optica

Autologous Transplant To End NMO Spectrum Disorder

ATTEND
Start date: November 2019
Phase: Phase 2/Phase 3
Study type: Interventional

This study is designed to treat your disease with an autologous stem cell transplant using a regimen of immune suppressant drugs and chemotherapy to reset your immune system and to determine if your disease will go into long-term remission.